The European healthcare technology (HealthTech) and medical technology (MedTech) landscape enters 2026 at a profound inflection point, characterised by a transition from the speculative fragmentation of the early 2020s to a disciplined era of "industrial maturity." Following a period of post-pandemic recalibration in 2024 and a tentative recovery in 2025, the market is poised for a robust, albeit structurally transformed, resurgence in mergers and acquisitions (M&A). The

The MedTech sector in 2026 stands at a pivotal juncture, defined by the convergence of rapid technological innovation, a maturing market demanding proven value, and a complex policy landscape. This report synthesizes these forces, moving from a macro-level analysis to specific, actionable insights. The industry is shifting from a focus on siloed technological advancements to an integrated, interconnected ecosystem where success hinges on the ability to operationalise innovati